Issues in experimental design and endpoint analysis in the study of experimental cytotoxic agents in vivo in breast cancer and other models.
about
Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesisStatistical approaches to experimental design and data analysis of in vivo studies.The role of preclinical animal models in breast cancer drug development.Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategyMonitoring the development of xenograft triple-negative breast cancer models using diffusion-weighted magnetic resonance imaging.K-RAS mutant pancreatic tumors show higher sensitivity to MEK than to PI3K inhibition in vivo.The oral HDAC inhibitor pracinostat (SB939) is efficacious and synergistic with the JAK2 inhibitor pacritinib (SB1518) in preclinical models of AML.Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models.Bench to bedside: the quest for quality in experimental stroke research.Synergistic antitumor efficacy against the EGFRvIII+HER2+ breast cancers by combining trastuzumab with anti-EGFRvIII antibody CH12VS-5584, a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancerOrally active alpha-tocopheryloxyacetic acid suppresses tumor growth and multiplicity of spontaneous murine breast cancer.In vitro and in vivo modulation of ABCG2 by functionalized aurones and structurally related analogs.Predictive observation-based endpoint criteria for mice receiving total body irradiationCombination of an anti-EGFRvIII antibody CH12 with Rapamycin synergistically inhibits the growth of EGFRvIII+PTEN-glioblastoma in vivo.Computed determination of the in vitro optimal chemocombinations of sphaeropsidin A with chemotherapeutic agents to combat melanomas.Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases.Liposomal or nanoparticle alpha-TEA reduced 66cl-4 murine mammary cancer burden and metastasis.CCN5/WISP-2 restores ER-∝ in normal and neoplastic breast cells and sensitizes triple negative breast cancer cells to tamoxifenAnimal models of breast cancer: experimental design and their use in nutrition and psychosocial research.Endpoint refinement for total body irradiation of C57BL/6 mice.Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis.Induction of experimental mammary carcinogenesis in rats with 7,12-dimethylbenz(a)anthracene.Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma.
P2860
Q24649679-31FF6006-026B-488B-B4F9-F4F30D08D43DQ32111107-37A80893-4334-492A-ADFB-9324DC0BDF08Q33555575-5C2F6A48-68C4-485B-8057-E8D7D465693CQ33683101-17B70308-6F52-4CFA-90D1-F1F01BB9B705Q33882146-399AB213-C2CE-492F-AEC8-44D133156F49Q34406302-B91DA93F-1432-4357-8305-14CED9B73A70Q34640790-30313926-6ABA-49EC-90DA-85A212B73213Q35287351-501ED4D4-BFCC-43FB-96D5-229BBE7E6590Q36416843-DED5625E-B772-4778-9B0C-D30C84F681A7Q36629433-3A3EE91C-4C02-44C2-83E8-9A6BACBE6B61Q36656352-78B9C02E-17E1-44CA-A03E-5FFC54790CF9Q36957648-6747376B-9D68-40C2-9E2B-28B9F77D085DQ37070476-49807886-6934-4FCE-8C55-04E4C15C95ADQ37113805-ACD7E894-3048-44A3-A175-25C25B2109D4Q37269431-1C594EC4-75D2-409F-8853-F7F622528DECQ38708463-FE3E40F6-6F88-40D7-AE9A-0AAE90AE5B48Q39816322-D3533C26-4DBF-409C-A8D5-7436BEFE9F5EQ40047732-18C17D2C-00A6-4E9B-BEBC-8A5DDE7033A2Q41505907-34B55214-0A12-4A76-82F3-779B646344E2Q41710247-30E75466-1D17-4130-8DB3-B34C45AE75B4Q42154414-6FA09AFD-09E1-46C1-99BC-12937FE4C535Q42477900-5CEE6292-3E5E-4707-A80B-3B7A07365604Q45150419-7D1D41EF-3BCF-4716-9C2E-C1F8E2DAC8EBQ46586294-C613BA5D-5589-42E7-B2F1-C567B40350E7
P2860
Issues in experimental design and endpoint analysis in the study of experimental cytotoxic agents in vivo in breast cancer and other models.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Issues in experimental design ...... reast cancer and other models.
@en
type
label
Issues in experimental design ...... reast cancer and other models.
@en
prefLabel
Issues in experimental design ...... reast cancer and other models.
@en
P2860
P356
P1476
Issues in experimental design ...... breast cancer and other models
@en
P2093
P2860
P2888
P304
P356
10.1023/A:1005938428456
P407
P577
1997-11-01T00:00:00Z
P6179
1046368219